Practical Review of Biologics in Chronic Rhinosinusitis With Nasal Polyps
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이기일 | - |
dc.contributor.author | 류광희 | - |
dc.contributor.author | 유신혁 | - |
dc.contributor.author | 김용민 | - |
dc.contributor.author | 모지훈 | - |
dc.contributor.author | 신승헌 | - |
dc.date.accessioned | 2021-12-07T09:40:19Z | - |
dc.date.available | 2021-12-07T09:40:19Z | - |
dc.date.issued | 2021-11 | - |
dc.identifier.issn | 1229-1498 | - |
dc.identifier.issn | 2384-4361 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/20087 | - |
dc.description.abstract | Well-characterized in chronic rhinosinusitis, type 2 inflammation is frequently associated with nasal polyps, comorbid asthma, and nonsteroidal anti-inflammatory drug hypersensitivity. Despite medical and surgical treatment, it recurs in a significant proportion of patients. Thus, severe uncontrolled type 2 chronic rhinosinusitis with nasal polyps is the most difficult-to-treat phenotype of chronic rhinosinusitis. Recently, dupilumab, a monoclonal antibody against IL-4 receptor α, and omalizumab, a monoclonal antibody against immunoglobulin E, were approved for patients with chronic rhinosinusitis with nasal polyps in the United States, Europe, and Korea. Therefore, rhinologists should understand novel biologics and their use. Here, we provide a literature review of several biologics with their indications, effectiveness, and safety. | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한비과학회 | - |
dc.title | Practical Review of Biologics in Chronic Rhinosinusitis With Nasal Polyps | - |
dc.title.alternative | Practical Review of Biologics in Chronic Rhinosinusitis With Nasal Polyps | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.18787/jr.2021.00382 | - |
dc.identifier.bibliographicCitation | Journal of Rhinology, v.28, no.3, pp 131 - 140 | - |
dc.citation.title | Journal of Rhinology | - |
dc.citation.volume | 28 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 131 | - |
dc.citation.endPage | 140 | - |
dc.identifier.kciid | ART002777724 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Biologics | - |
dc.subject.keywordAuthor | Sinusitis | - |
dc.subject.keywordAuthor | Immunology | - |
dc.subject.keywordAuthor | Nasal polyps | - |
dc.subject.keywordAuthor | Interleukin-4 receptors | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.